446 related articles for article (PubMed ID: 16220491)
1. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
Sheng D; Kim MY
Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity analysis of intention-to-treat estimates when withdrawals are related to unobserved compliance status.
Salim A; Mackinnon A; Griffiths K
Stat Med; 2008 Apr; 27(8):1164-79. PubMed ID: 17724782
[TBL] [Abstract][Full Text] [Related]
3. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
Matilde Sanchez M; Chen X
Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
[TBL] [Abstract][Full Text] [Related]
4. The effects of outcome misclassification and measurement error on the design and analysis of therapeutic equivalence trials.
Kim MY; Goldberg JD
Stat Med; 2001 Jul; 20(14):2065-78. PubMed ID: 11439421
[TBL] [Abstract][Full Text] [Related]
5. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
Lui KJ; Chang KC
Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
[TBL] [Abstract][Full Text] [Related]
6. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
Greenland S; Lanes S; Jara M
Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic equivalence: fallacies and falsification.
Garrett AD
Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103
[TBL] [Abstract][Full Text] [Related]
8. Methodology of superiority vs. equivalence trials and non-inferiority trials.
Christensen E
J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
[TBL] [Abstract][Full Text] [Related]
9. Discordant conclusions from HIV clinical trials--an evaluation of efficacy endpoints.
Hill A; Demasi R
Antivir Ther; 2005; 10(3):367-74. PubMed ID: 15918328
[TBL] [Abstract][Full Text] [Related]
10. Compliance in clinical trials: impact on design, analysis and interpretation.
Pledger GW
Epilepsy Res Suppl; 1988; 1():125-33. PubMed ID: 3072187
[TBL] [Abstract][Full Text] [Related]
11. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
Liu JP; Ma MC; Wu CY; Tai JY
Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
[TBL] [Abstract][Full Text] [Related]
12. Analysing non-compliance in clinical trials: ethical imperative or mission impossible?
Goetghebeur EJ; Shapiro SH
Stat Med; 1996 Dec; 15(24):2813-26. PubMed ID: 8981688
[TBL] [Abstract][Full Text] [Related]
13. Weighting in instrumental variables and G-estimation.
Joffe MM; Brensinger C
Stat Med; 2003 Apr; 22(8):1285-303. PubMed ID: 12687655
[TBL] [Abstract][Full Text] [Related]
14. A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcome.
Hollis S
Stat Med; 2002 Dec; 21(24):3823-34. PubMed ID: 12483769
[TBL] [Abstract][Full Text] [Related]
15. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
Bang H; Davis CE
Stat Med; 2007 Feb; 26(5):954-64. PubMed ID: 16900559
[TBL] [Abstract][Full Text] [Related]
16. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
Dilba G; Bretz F; Hothorn LA; Guiard V
Stat Med; 2006 Apr; 25(7):1131-47. PubMed ID: 16217842
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of experimental treatments compared with standard treatments in non-inferiority trials: a meta-analysis of randomized controlled trials.
Soonawala D; Middelburg RA; Egger M; Vandenbroucke JP; Dekkers OM
Int J Epidemiol; 2010 Dec; 39(6):1567-81. PubMed ID: 20837637
[TBL] [Abstract][Full Text] [Related]
18. Blinded sample size reassessment in non-inferiority and equivalence trials.
Friede T; Kieser M
Stat Med; 2003 Mar; 22(6):995-1007. PubMed ID: 12627414
[TBL] [Abstract][Full Text] [Related]
19. [Methodological and statistical aspects of equivalence and non inferiority trials].
Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
[TBL] [Abstract][Full Text] [Related]
20. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
Lui KJ
Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
